Document Preview Unavailable

Real-world analysis of afatinib as a first-line treatment for patients with advanced stage non-small-cell lung cancer with uncommon EGFR mutations: a multicenter study in Vietnam

Pham Van Luan; Le, Tuan Anh; Pham Cam Phuong; Hoa Nguyen Thi Thai; Tu, Do Anh; et al.  Therapeutic Advances in Medical Oncology Vol. 16,  (Jan 2024).

You might have access to this document